Tanguay; Jean-Francois

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tanguay; Jean-Francois.The latest application filed is for "method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening".

Company Profile

0.3.9

Tanguay; Jean-Francois - Montreal CA
Tanguay; Jean-Francois - Ville Mont-Royal CA
Tanguay; Jean-Francois - Montroyal CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Reducing The Effects Of Cytostatic Drugs On Bone Marrow Derived Cells, And Methods Of Screening App 20100247602 - Tanguay; Jean-Francois	2010-09-30
Implantable Devices For Promoting Reendothelialization And Methods Of Use Thereof App 20090274738 - TANGUAY; Jean-Francois	2009-11-05
Modulation of the Expression of Estrogen Receptors for the Prevention or Treatment of Heart Disease App 20080214517 - Tanguay; Jean-Francois ; et al.	2008-09-04
Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction Grant 7,323,461 - Juneau , et al. January 29, 2	2008-01-29
Antisense strategy to modulate estrogen receptor response (ER .alpha. and/or ER .beta. ) Grant 7,235,534 - Tanguay , et al. June 26, 2	2007-06-26
Local Deliver of 17-Beta Estradiol for Preventing Vascular Intimal Hyperplasia and for Improving Vascular Endothelium Function after Vascular Injury App 20070141109 - Chadrasekar; Baskaran ; et al.	2007-06-21
Modulation of the expression of estrogen receptors for the prevention or treatment of heart disease App 20050065065 - Tanguay, Jean-Francois ; et al.	2005-03-24
Local delivery of 17-beta estradiol for preventing vascular intimal hyperplasia and for improving vascular endothelium function after vascular injury App 20040229856 - Chandrasekar, Baskaran ; et al.	2004-11-18
Inhibition of stenosis or restenosis by P-selectin ligand antagonists App 20040086519 - Kumar, Anjali ; et al.	2004-05-06
Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction App 20030219495 - Juneau, Martin ; et al.	2003-11-27
Antisense strategy to modulate estrogen receptor response (ER alpha and/or ER beta) App 20030144240 - Tanguay, Jean-Francois ; et al.	2003-07-31
Method for inhibiting restenosis Grant 6,241,718 - Arless , et al. June 5, 2	2001-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.